PDE4 inhibitor rolipram induced cell cycle arrest and apoptosis [63], and overexpression of PDE4B resulted in diffuse large cell lymphoma (DLBCL); a fatal malignancy indicating that PDE4B inhibitors could be useful anticancer agents [64]. Here, PDE4B is linked to diffuse large B-cell lymphoma.